Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer

Pagani, O.O.PaganiSessa, C.C.SessaMartinelli, G.G.MartinelliCrivellari, D.D.CrivellariBuonadonna, A.A.BuonadonnaThürlimann, B.B.ThürlimannHess, D.D.HessBorner, MarkusMarkusBornerBauer, J.J.BauerZampino, G.G.ZampinoZimatore, M.M.ZimatoreGraffeo, R.R.GraffeoRiva, A.A.RivaGoldhirsch, A.A.Goldhirsch2024-10-252024-10-251999https://boris-portal.unibe.ch/handle/20.500.12422/160783en600 - Technology::610 - Medicine & healthDose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancerarticle10.7892/boris.11496210.1023/A:1026437731354